UW–Madison, FluGen, Bharat Biotech to develop CoroFlu, a coronavirus vaccine

Kawaokas lab will insert gene sequences from SARS-CoV-2, the novel coronavirus that causes the disease COVID-19, into M2SR so that the new vaccine will also induce immunity against the coronavirus.